<p>10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc (EYPT.O)：* Eyepoint Pharmaceuticals Inc - 宣布启动针对糖尿病性黄斑水肿的 Duravy 的第三阶段项目 来源文本：进一步公司报道：（EYPT.O）</p>

EYPT

<p>10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc：* Eyepoint Pharmaceuticals Inc - 宣布启动针对糖尿病性黄斑水肿的 DURAVY 的第三阶段项目 来源文本：进一步的公司报道：</p>

<p>Oct 14 (Reuters) - EyePoint Pharmaceuticals Inc (EYPT.O) :
* EYEPOINT PHARMACEUTICALS INC - ANNOUNCES PHASE 3 PROGRAM INITIATION FOR DURAVY IN DIABETIC MACULAR EDEMA Source text: Further company coverage: (EYPT.O)</p>
<div class="lb-trans"><p>10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc (EYPT.O)：* Eyepoint Pharmaceuticals Inc - 宣布启动针对糖尿病性黄斑水肿的 Duravy 的第三阶段项目 来源文本：进一步公司报道：（EYPT.O）</p>
</div>

Eyepoint Pharmaceuticals 宣布启动 Duravy 用于治疗糖尿病黄斑水肿的三期临床项目